home / stock / snbp / snbp short
Short Information | Sun BioPharma Inc (OTCMKTS:SNBP)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 9,109 |
Total Actual Volume | 13,009 |
Short Trends | |
---|---|
Cover Days | 5 |
Short Days | 12 |
No Change Days | 3 |
Averages | |
---|---|
Average Short Volume | 455 |
Average Short Percentage | 59.67% |
Is there a SNBP Short Squeeze or Breakout about to happen?
See the SNBP Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
08-27-2020 | $9.5 | $9.5 | $9.5 | $9.5 | 126 | 25 | 19.84% |
08-26-2020 | $9.75 | $9.25 | $9.75 | $9 | 880 | 400 | 45.45% |
08-24-2020 | $9.5 | $9.49 | $9.5 | $9.49 | 368 | 300 | 81.52% |
08-21-2020 | $7.75 | $7.75 | $7.75 | $7.75 | 225 | 200 | 88.89% |
08-20-2020 | $7 | $7 | $7 | $7 | 515 | 85 | 16.5% |
08-17-2020 | $9.5 | $8.75 | $9.5 | $8.75 | 1,810 | 1,800 | 99.45% |
08-14-2020 | $9.5 | $9.5 | $9.5 | $9.5 | 182 | 100 | 54.95% |
08-13-2020 | $9.5 | $9.5 | $9.5 | $9.5 | 500 | 3 | 0.6% |
08-12-2020 | $9.46 | $9.5 | $9.5 | $9.46 | 1,027 | 500 | 48.69% |
08-11-2020 | $8.75 | $8.75 | $8.75 | $8.75 | 200 | 100 | 50% |
08-07-2020 | $7.75 | $7.75 | $7.75 | $7.75 | 100 | 100 | 100% |
08-06-2020 | $7.75 | $7.75 | $7.75 | $7.75 | 244 | 144 | 59.02% |
07-24-2020 | $7.26 | $6.3 | $7.26 | $6.3 | 308 | 200 | 64.94% |
07-22-2020 | $9.5 | $9.5 | $9.5 | $9.5 | 625 | 620 | 99.2% |
07-21-2020 | $8 | $8 | $8 | $8 | 112 | 12 | 10.71% |
07-15-2020 | $9.5 | $9.5 | $9.5 | $9.01 | 2,431 | 2,605 | 107.16% |
07-14-2020 | $8 | $10 | $10 | $8 | 1,785 | 1,220 | 68.35% |
07-10-2020 | $7 | $7.5 | $7.5 | $6.8 | 946 | 300 | 31.71% |
07-08-2020 | $6.5 | $6.5 | $6.5 | $6.325 | 430 | 200 | 46.51% |
07-07-2020 | $6.5 | $6.5 | $6.5 | $6.5 | 195 | 195 | 100% |
News, Short Squeeze, Breakout and More Instantly...
MINNEAPOLIS, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, has completed patient enrollment in its Phase 1 trial evaluating the s...
MINNEAPOLIS, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (Nasdaq: SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, has announced the change of its corporate name to Panbela Therapeutics, Inc. effective ...
MINNEAPOLIS, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (Nasdaq: SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with pancreatic cancer, today provides a business update and reports financial results for the quart...